“…6,7 Further, care must be taken to consider confounding variables such as diet, obesity, diabetes, and smoker status. [8][9][10] There is a growing appreciation of the value of analyzing routinely collected patient samples for relevant biomarkers in various fields, such as breast cancer, liver fibrosis, osteoporosis, and cardiovascular disease. [11][12][13][14] However, to our knowledge, there are no comprehensive studies examining the utility of multiple routinely measured biomarkers in SCI patients, despite the success of such techniques in the fields of Alzheimer's disease, cancer, and osteoarthritis.…”